The US Food and Drug Administration approved the type 2 diabetes drug tirzepatide for use in chronic weight management Wednesday, making official the use of ...
The U.S. Food and Drug Administration approved the drug Zepbound for obesity to help people lose weight on Wednesday.
The drug has been shown to help dieters lose about a quarter of their body weight, or 60 pounds. It is the latest diabetes drug approved for weight loss, ...
The obesity approval for tirzepatide introduces stiff competition for Novo Nordisk, which has had shortages of its obesity treatment Wegovy.
Britain's health regulator on Wednesday authorised Eli Lilly's diabetes drug Mounjaro for weight management and weight loss in the UK, hours after a similar ...
A new version of the popular diabetes treatment Mounjaro can be sold as a weight-loss drug, U.S. regulators announced Wednesday.
Trials suggest it can help people shed about 20% of body weight, but it is not recommended for NHS use yet.